News
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...
A MUM who slimmed down five dress sizes thanks to Mounjaro has shared her top tips for those wanting to shed weight with fat jabs. Katie McCutcheon, from Glasgow, Scotland, who lost over 5st in ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
The proportion of severely overweight children in the US has skyrocketed in recent years, with the highest rates seen in adolescents and Black children, a new study found.
Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...
Medical tourism for bariatric and weight reduction surgery needs urgent regulation to protect recipients' health, especially as the data show that tourist numbers are increasing despite the advent of ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.
Biocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027.
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results